A commonly used marker of tumour proliferation is Ki-67 (MIB-1), a monoclonal antibody recognising a nuclear protein expressed in all active phases of the cell cycle (G1, S, G2 and M) but absent in quiescent cells (G0) (Cattoretti et al, 1992). Here, MKI67 is linked to neoplasm.